Phase I trial of ITV-1, a peptide vaccine for HIV-AIDS, in volunteers in Bulgaria

Trial Profile

Phase I trial of ITV-1, a peptide vaccine for HIV-AIDS, in volunteers in Bulgaria

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2013

At a glance

  • Drugs ITV 1 (Primary)
  • Indications Acquired immunodeficiency syndrome; HIV infections
  • Focus Adverse reactions
  • Sponsors Immunotech Laboratories
  • Most Recent Events

    • 15 Feb 2013 New trial record
    • 13 Feb 2013 Results have been highly successful in Bulgaria, according to an Immunotech Laboratories media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top